American Society of Hirudotherapy

Non-Occlusive Mesenteric Ischemia Due to Hirudotherapy: A Case Report

Akalın Ç, Ekmen N (2020) · Cureus · 1 patient

Case-level evidence: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
GRADE Very LowCase reportAdverse events of leech therapy

Study Profile

Design
single-patient case report (57-year-old male, Ordu University Training and Research Hospital, Turkey)
Patient
1
Presentation and intervention
Hirudotherapy applied to diabetic foot wounds with subsequent prolonged uncontrollable bleeding and non-occlusive mesenteric ischemia
Outcome
Excessive bleeding from leech bites caused hypovolemia and non-occlusive mesenteric ischemia; CT showed hepatic portal venous gas and pneumatosis intestinalis; laparotomy revealed necrosis of terminal ileum and entire colon; necrotic segments resected with end-ileostomy; patient discharged day 17
Follow-up duration
17 days hospitalization with surgical resection

Key Findings

  • Non-occlusive mesenteric ischemia from hirudotherapy bleeding
  • Hypovolemia-driven splanchnic hypoperfusion
  • Necrosis of terminal ileum and entire colon required resection
  • End-ileostomy permanent at discharge
  • Critical safety signal for unsupervised hirudotherapy

Limitations

  • Single case - cannot quantify incidence
  • Diabetic foot wound treatment context may amplify risk
  • Unable to establish causal link with full certainty
  • Cannot recommend protocol changes from single case
  • Patient demographics specific to Turkish clinical context

Clinical Implications

Akalın 2020 documents a catastrophic outcome (ischemic bowel necrosis requiring colectomy) from prolonged bleeding after off-label hirudotherapy for diabetic foot wounds. For US clinicians under K040187, this case reinforces the device's restricted indication (postoperative venous congestion in supervised settings) and the dangers of unsupervised use. Critical patient safety education content.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.